BAX · Full Picture

BAXTER INTERNATIONAL INC — the full picture

Trailing window · 2026-05-12 to 2026-08-10

One earnings window, everything merged: the filing, the call, press releases and news digests, folded into ranked threads.

What to look at first

Outstanding Indebtedness · Debt, leverage & refinancingPriority 64
2 sources (news, press_release); 3 forward row(s); quote_verified
Baxter commenced cash tender offers for notes such that the aggregate purchase price, not including accrued and unpaid interest, payable in respect of such Notes will not exceed $500 million.
Product Safety Recall · UnclassifiedPriority 30
quote_verified
The lawsuit claims Baxter made false statements and concealed systemic defects in its Novum LVP product, leading to widespread malfunctions and patient harm.
Leadership Transition · Leadership & organizationPriority 29
quote_verified
Interim Chief Financial Officer Anita Zielinski will resign effective September 15, 2026.
Securities Fraud Litigation · Litigation & settlementsPriority 27
quote_verified
Investors are encouraged to contact Levi & Korsinsky before December 15, 2025 to learn about their rights to recover losses.